| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 4.59e-08 | 109 | 94 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 9.46e-08 | 10 | 94 | 4 | GO:0043225 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.10e-07 | 49 | 94 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | transporter activity | PITPNM2 SLC17A2 SLC46A2 SLC25A41 ATP2C1 SLC18A1 SLC2A6 CFTR ATP2C2 SCNN1D MFSD9 ABCC5 ABCC11 ABCC12 APOB SLC40A1 ABCG5 ABCC6 SLC2A2 MFSD3 SLC4A11 | 4.39e-07 | 1289 | 94 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | SMARCA5 ATP2C1 KIF27 CFTR ATP2C2 ABCC5 ABCC11 MACF1 ABCC12 CHD1L ABCG5 ABCC6 | 1.08e-06 | 441 | 94 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.97e-06 | 178 | 94 | 8 | GO:0015399 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC17A2 SLC46A2 SLC25A41 ATP2C1 SLC18A1 SLC2A6 CFTR ATP2C2 SCNN1D MFSD9 ABCC5 ABCC11 ABCC12 SLC40A1 ABCG5 ABCC6 SLC2A2 MFSD3 SLC4A11 | 2.05e-06 | 1180 | 94 | 19 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC17A2 SLC46A2 ATP2C1 SLC18A1 CFTR ATP2C2 ABCC5 ABCC11 ABCC12 ABCG5 ABCC6 SLC4A11 | 2.44e-06 | 477 | 94 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | ATP-dependent activity | SMARCA5 ATP2C1 KIF27 CFTR ATP2C2 SMARCA1 ABCC5 ABCC11 MACF1 ABCC12 CHD1L ABCG5 ABCC6 | 5.94e-06 | 614 | 94 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 9.99e-06 | 29 | 94 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.63e-05 | 171 | 94 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 1.70e-05 | 33 | 94 | 4 | GO:0015215 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.92e-05 | 34 | 94 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | P-type manganese transporter activity | 2.19e-05 | 2 | 94 | 2 | GO:0140613 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 3.34e-05 | 39 | 94 | 4 | GO:0015605 | |
| GeneOntologyMolecularFunction | D-glucose binding | 3.54e-05 | 14 | 94 | 3 | GO:0005536 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 4.41e-05 | 15 | 94 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 7.30e-05 | 293 | 94 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.72e-04 | 59 | 94 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | glucokinase activity | 2.17e-04 | 5 | 94 | 2 | GO:0004340 | |
| GeneOntologyMolecularFunction | hexokinase activity | 2.17e-04 | 5 | 94 | 2 | GO:0004396 | |
| GeneOntologyMolecularFunction | fructokinase activity | 2.17e-04 | 5 | 94 | 2 | GO:0008865 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | SMARCA5 ATP2C1 KIF27 CFTR ATP2C2 ABCC5 ABCC11 MACF1 ABCC12 CHD1L ABCG5 ABCC6 | 2.77e-04 | 775 | 94 | 12 | GO:0017111 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.74e-04 | 130 | 94 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | prolactin receptor binding | 4.53e-04 | 7 | 94 | 2 | GO:0005148 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | SMARCA5 ATP2C1 KIF27 CFTR ATP2C2 ABCC5 ABCC11 MACF1 ABCC12 CHD1L ABCG5 ABCC6 | 5.64e-04 | 839 | 94 | 12 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | SMARCA5 ATP2C1 KIF27 CFTR ATP2C2 ABCC5 ABCC11 MACF1 ABCC12 CHD1L ABCG5 ABCC6 | 5.70e-04 | 840 | 94 | 12 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | SMARCA5 ATP2C1 KIF27 CFTR ATP2C2 ABCC5 ABCC11 MACF1 ABCC12 CHD1L ABCG5 ABCC6 | 5.70e-04 | 840 | 94 | 12 | GO:0016818 |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 6.03e-04 | 8 | 94 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | dehydroascorbic acid transmembrane transporter activity | 6.03e-04 | 8 | 94 | 2 | GO:0033300 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 6.99e-04 | 37 | 94 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 7.73e-04 | 9 | 94 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC17A2 ATP2C1 SLC18A1 CFTR ATP2C2 SCNN1D ABCC5 ABCC11 SLC40A1 ABCC6 SLC4A11 | 8.62e-04 | 758 | 94 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | manganese ion transmembrane transporter activity | 9.63e-04 | 10 | 94 | 2 | GO:0005384 | |
| GeneOntologyMolecularFunction | growth hormone receptor binding | 9.63e-04 | 10 | 94 | 2 | GO:0005131 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.16e-03 | 44 | 94 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 1.17e-03 | 11 | 94 | 2 | GO:0005388 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 2.46e-03 | 57 | 94 | 3 | GO:0120013 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 2.71e-03 | 59 | 94 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 2.98e-03 | 61 | 94 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 4.34e-03 | 21 | 94 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 5.20e-03 | 23 | 94 | 2 | GO:0005346 | |
| GeneOntologyMolecularFunction | symporter activity | 5.53e-03 | 150 | 94 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | cholesterol transfer activity | 5.66e-03 | 24 | 94 | 2 | GO:0120020 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 6.13e-03 | 25 | 94 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | sterol transfer activity | 6.13e-03 | 25 | 94 | 2 | GO:0120015 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 6.13e-03 | 25 | 94 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.38e-03 | 465 | 94 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 6.62e-03 | 26 | 94 | 2 | GO:0000295 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.76e-06 | 44 | 95 | 5 | GO:0015865 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 3.35e-06 | 50 | 95 | 5 | GO:0006862 | |
| GeneOntologyBiologicalProcess | organic anion transport | SLC17A2 SLC46A2 SLC25A41 SLC2A6 CFTR NFKBIE ABCC5 ABCC11 ABCC6 SLC2A2 SLC4A11 | 2.49e-05 | 515 | 95 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 3.40e-05 | 40 | 95 | 4 | GO:0015868 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 4.13e-05 | 42 | 95 | 4 | GO:0051503 | |
| GeneOntologyBiologicalProcess | organophosphate ester transport | 1.04e-04 | 162 | 95 | 6 | GO:0015748 | |
| GeneOntologyCellularComponent | basal part of cell | 5.17e-05 | 378 | 94 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | apical plasma membrane | SLC17A2 DSG1 CFTR ABCC5 ABCC11 PLEC ABCG5 ABCC6 SLC2A2 SLC4A11 | 6.75e-05 | 487 | 94 | 10 | GO:0016324 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.96e-04 | 354 | 94 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | growth hormone receptor complex | 2.97e-04 | 6 | 94 | 2 | GO:0070195 | |
| GeneOntologyCellularComponent | apical part of cell | SLC17A2 DSG1 CFTR ABCC5 ABCC11 PLEC ABCG5 ABCC6 SLC2A2 SLC4A11 | 3.29e-04 | 592 | 94 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | NURF complex | 4.14e-04 | 7 | 94 | 2 | GO:0016589 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 6.05e-04 | 320 | 94 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | endosome lumen | 9.54e-04 | 43 | 94 | 3 | GO:0031904 | |
| GeneOntologyCellularComponent | chylomicron | 1.51e-03 | 13 | 94 | 2 | GO:0042627 | |
| GeneOntologyCellularComponent | ISWI-type complex | 1.76e-03 | 14 | 94 | 2 | GO:0031010 | |
| Domain | ABC_membrane | 1.03e-07 | 24 | 92 | 5 | PF00664 | |
| Domain | ABC_tran | 1.26e-07 | 48 | 92 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.26e-07 | 48 | 92 | 6 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.43e-07 | 49 | 92 | 6 | PS00211 | |
| Domain | ABC_transporter-like | 1.62e-07 | 50 | 92 | 6 | IPR003439 | |
| Domain | ABC_TM1F | 2.33e-07 | 28 | 92 | 5 | PS50929 | |
| Domain | ABC1_TM_dom | 2.33e-07 | 28 | 92 | 5 | IPR011527 | |
| Domain | MFS_dom | 3.19e-07 | 134 | 92 | 8 | IPR020846 | |
| Domain | MFS | 1.04e-06 | 108 | 92 | 7 | PS50850 | |
| Domain | ABC_transporter_CS | 1.91e-06 | 42 | 92 | 5 | IPR017871 | |
| Domain | Alpha_tubulin | 9.51e-06 | 9 | 92 | 3 | IPR002452 | |
| Domain | SLIDE | 2.40e-05 | 2 | 92 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 2.40e-05 | 2 | 92 | 2 | IPR015194 | |
| Domain | SLIDE | 2.40e-05 | 2 | 92 | 2 | PF09111 | |
| Domain | HAND | 2.40e-05 | 2 | 92 | 2 | PF09110 | |
| Domain | P-type_ATPase_IIA_PMR1 | 2.40e-05 | 2 | 92 | 2 | IPR006413 | |
| Domain | ISWI | 2.40e-05 | 2 | 92 | 2 | IPR029915 | |
| Domain | MFS_1 | 3.88e-05 | 77 | 92 | 5 | PF07690 | |
| Domain | MFS | 3.88e-05 | 77 | 92 | 5 | IPR011701 | |
| Domain | DBINO | 7.18e-05 | 3 | 92 | 2 | PF13892 | |
| Domain | DBINO | 7.18e-05 | 3 | 92 | 2 | IPR020838 | |
| Domain | AAA+_ATPase | 7.83e-05 | 144 | 92 | 6 | IPR003593 | |
| Domain | AAA | 7.83e-05 | 144 | 92 | 6 | SM00382 | |
| Domain | - | 1.24e-04 | 20 | 92 | 3 | 3.30.1330.20 | |
| Domain | - | 1.44e-04 | 21 | 92 | 3 | 1.10.287.600 | |
| Domain | Tubulin_C | 1.66e-04 | 22 | 92 | 3 | SM00865 | |
| Domain | Tubulin_C | 1.66e-04 | 22 | 92 | 3 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.66e-04 | 22 | 92 | 3 | IPR018316 | |
| Domain | - | 1.66e-04 | 22 | 92 | 3 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.91e-04 | 23 | 92 | 3 | IPR023123 | |
| Domain | TUBULIN | 1.91e-04 | 23 | 92 | 3 | PS00227 | |
| Domain | Tubulin | 1.91e-04 | 23 | 92 | 3 | IPR000217 | |
| Domain | Tub_FtsZ_C | 1.91e-04 | 23 | 92 | 3 | IPR008280 | |
| Domain | Tubulin | 1.91e-04 | 23 | 92 | 3 | SM00864 | |
| Domain | Tubulin_CS | 1.91e-04 | 23 | 92 | 3 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.17e-04 | 24 | 92 | 3 | IPR003008 | |
| Domain | Tubulin | 2.17e-04 | 24 | 92 | 3 | PF00091 | |
| Domain | Hexokinase_C | 2.38e-04 | 5 | 92 | 2 | IPR022673 | |
| Domain | Hexokinase_N | 2.38e-04 | 5 | 92 | 2 | IPR022672 | |
| Domain | Hexokinase_1 | 2.38e-04 | 5 | 92 | 2 | PF00349 | |
| Domain | Tet-R_TetA/multi-R_MdtG | 2.38e-04 | 5 | 92 | 2 | IPR001958 | |
| Domain | Hexokinase_2 | 2.38e-04 | 5 | 92 | 2 | PF03727 | |
| Domain | CPSASE_1 | 2.38e-04 | 5 | 92 | 2 | PS00866 | |
| Domain | Somatotropin_CS | 2.38e-04 | 5 | 92 | 2 | IPR018116 | |
| Domain | HEXOKINASE_2 | 2.38e-04 | 5 | 92 | 2 | PS51748 | |
| Domain | Hexokinase_BS | 2.38e-04 | 5 | 92 | 2 | IPR019807 | |
| Domain | HEXOKINASE_1 | 2.38e-04 | 5 | 92 | 2 | PS00378 | |
| Domain | Hexokinase | 3.55e-04 | 6 | 92 | 2 | IPR001312 | |
| Domain | - | 3.55e-04 | 6 | 92 | 2 | 3.90.1290.10 | |
| Domain | SOMATOTROPIN_2 | 3.55e-04 | 6 | 92 | 2 | PS00338 | |
| Domain | Hormone_1 | 3.55e-04 | 6 | 92 | 2 | PF00103 | |
| Domain | CPSASE_2 | 3.55e-04 | 6 | 92 | 2 | PS00867 | |
| Domain | DDHD | 3.55e-04 | 6 | 92 | 2 | PF02862 | |
| Domain | DDHD | 3.55e-04 | 6 | 92 | 2 | PS51043 | |
| Domain | DDHD_dom | 3.55e-04 | 6 | 92 | 2 | IPR004177 | |
| Domain | SOMATOTROPIN_1 | 3.55e-04 | 6 | 92 | 2 | PS00266 | |
| Domain | DDHD | 3.55e-04 | 6 | 92 | 2 | SM01127 | |
| Domain | Plectin_repeat | 4.96e-04 | 7 | 92 | 2 | IPR001101 | |
| Domain | Somatotropin | 4.96e-04 | 7 | 92 | 2 | IPR001400 | |
| Domain | CPSase_L_D2 | 4.96e-04 | 7 | 92 | 2 | PF02786 | |
| Domain | Plectin | 4.96e-04 | 7 | 92 | 2 | PF00681 | |
| Domain | CbamoylP_synth_lsu-like_ATP-bd | 4.96e-04 | 7 | 92 | 2 | IPR005479 | |
| Domain | BC-like_N | 4.96e-04 | 7 | 92 | 2 | IPR005481 | |
| Domain | Biotin_carb_N | 4.96e-04 | 7 | 92 | 2 | PF00289 | |
| Domain | PLEC | 4.96e-04 | 7 | 92 | 2 | SM00250 | |
| Domain | Sugar_transporter_CS | 5.17e-04 | 32 | 92 | 3 | IPR005829 | |
| Domain | SNF2_N | 5.17e-04 | 32 | 92 | 3 | IPR000330 | |
| Domain | SNF2_N | 5.17e-04 | 32 | 92 | 3 | PF00176 | |
| Domain | DEAH_ATP_HELICASE | 8.61e-04 | 38 | 92 | 3 | PS00690 | |
| Domain | - | 1.81e-03 | 13 | 92 | 2 | 3.40.50.20 | |
| Domain | IBR | 2.10e-03 | 14 | 92 | 2 | SM00647 | |
| Domain | ATP-grasp | 2.10e-03 | 14 | 92 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 2.10e-03 | 14 | 92 | 2 | IPR016185 | |
| Domain | IBR | 2.10e-03 | 14 | 92 | 2 | PF01485 | |
| Domain | ATP_GRASP | 2.10e-03 | 14 | 92 | 2 | PS50975 | |
| Domain | Sugar/inositol_transpt | 2.10e-03 | 14 | 92 | 2 | IPR003663 | |
| Domain | IBR_dom | 2.42e-03 | 15 | 92 | 2 | IPR002867 | |
| Domain | - | 2.42e-03 | 15 | 92 | 2 | 3.30.1490.20 | |
| Domain | - | 2.75e-03 | 16 | 92 | 2 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.75e-03 | 16 | 92 | 2 | IPR023298 | |
| Domain | SUGAR_TRANSPORT_2 | 3.11e-03 | 17 | 92 | 2 | PS00217 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.11e-03 | 17 | 92 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.11e-03 | 17 | 92 | 2 | PF00689 | |
| Domain | ATP_grasp_subdomain_1 | 3.49e-03 | 18 | 92 | 2 | IPR013815 | |
| Domain | Cation_ATPase_N | 3.49e-03 | 18 | 92 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 3.49e-03 | 18 | 92 | 2 | SM00831 | |
| Domain | - | 3.49e-03 | 18 | 92 | 2 | 3.30.470.20 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.89e-03 | 19 | 92 | 2 | IPR004014 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 8.69e-08 | 44 | 72 | 6 | M11911 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | LSR ADCY4 ATP2C1 SLC18A1 SLC2A6 CFTR ATP2C2 PSMB9 SCNN1D ABCC5 ABCC11 APOB SLC40A1 ABCG5 ABCC6 SLC2A2 | 6.85e-07 | 736 | 72 | 16 | M27287 |
| Pathway | REACTOME_AGGREPHAGY | 2.81e-06 | 44 | 72 | 5 | M29830 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 3.18e-06 | 177 | 72 | 8 | M27476 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.51e-06 | 21 | 72 | 4 | M27067 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 5.15e-06 | 23 | 72 | 4 | M19135 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 8.59e-06 | 26 | 72 | 4 | M9648 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 1.35e-05 | 29 | 72 | 4 | M27948 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.39e-05 | 103 | 72 | 6 | M758 | |
| Pathway | REACTOME_KINESINS | 1.44e-05 | 61 | 72 | 5 | M977 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.02e-05 | 32 | 72 | 4 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.02e-05 | 32 | 72 | 4 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 2.29e-05 | 33 | 72 | 4 | M27297 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 3.03e-05 | 71 | 72 | 5 | M39690 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.05e-05 | 38 | 72 | 4 | M14981 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 4.21e-05 | 76 | 72 | 5 | M27215 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 5.07e-05 | 79 | 72 | 5 | M27743 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.28e-05 | 44 | 72 | 4 | M27934 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 8.25e-05 | 17 | 72 | 3 | M47768 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 8.68e-05 | 46 | 72 | 4 | M27828 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 9.47e-05 | 90 | 72 | 5 | M29841 | |
| Pathway | KEGG_GAP_JUNCTION | 9.47e-05 | 90 | 72 | 5 | M4013 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 9.87e-05 | 18 | 72 | 3 | M47753 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.11e-04 | 49 | 72 | 4 | M891 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.17e-04 | 19 | 72 | 3 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.17e-04 | 19 | 72 | 3 | M47813 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.30e-04 | 51 | 72 | 4 | M26972 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.37e-04 | 20 | 72 | 3 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.37e-04 | 20 | 72 | 3 | M47911 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.52e-04 | 53 | 72 | 4 | M27651 | |
| Pathway | REACTOME_AUTOPHAGY | 1.53e-04 | 158 | 72 | 6 | M27935 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.56e-04 | 100 | 72 | 5 | M27650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.59e-04 | 21 | 72 | 3 | M47767 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.75e-04 | 55 | 72 | 4 | M39613 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.75e-04 | 162 | 72 | 6 | M29804 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 1.83e-04 | 22 | 72 | 3 | M47903 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.88e-04 | 56 | 72 | 4 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 2.01e-04 | 57 | 72 | 4 | M27251 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 2.10e-04 | 23 | 72 | 3 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 2.10e-04 | 23 | 72 | 3 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 2.39e-04 | 24 | 72 | 3 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.39e-04 | 24 | 72 | 3 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.71e-04 | 25 | 72 | 3 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.71e-04 | 25 | 72 | 3 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.05e-04 | 26 | 72 | 3 | M47672 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.79e-04 | 121 | 72 | 5 | M872 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS | 3.81e-04 | 6 | 72 | 2 | M47654 | |
| Pathway | REACTOME_VLDL_CLEARANCE | 3.81e-04 | 6 | 72 | 2 | M27848 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 3.82e-04 | 28 | 72 | 3 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.82e-04 | 28 | 72 | 3 | M47898 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 4.25e-04 | 191 | 72 | 6 | M29614 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 4.74e-04 | 127 | 72 | 5 | M27181 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 4.95e-04 | 72 | 72 | 4 | M26954 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 5.31e-04 | 7 | 72 | 2 | M47646 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 6.05e-04 | 134 | 72 | 5 | M27751 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 6.08e-04 | 76 | 72 | 4 | M48037 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 6.24e-04 | 33 | 72 | 3 | M47901 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP2C1 SLC18A1 SLC2A6 CFTR ATP2C2 ABCC5 APOB SLC40A1 ABCG5 ABCC6 SLC2A2 | 6.32e-04 | 681 | 72 | 11 | MM14985 |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 6.71e-04 | 78 | 72 | 4 | M27473 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 6.91e-04 | 138 | 72 | 5 | M29805 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.38e-04 | 140 | 72 | 5 | M27550 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.44e-04 | 35 | 72 | 3 | M47774 | |
| Pathway | REACTOME_AGGREPHAGY | 8.08e-04 | 36 | 72 | 3 | MM15669 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.04e-03 | 151 | 72 | 5 | M550 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 1.10e-03 | 40 | 72 | 3 | M39595 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.28e-03 | 236 | 72 | 6 | M27185 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.35e-03 | 94 | 72 | 4 | M2843 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.36e-03 | 43 | 72 | 3 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.36e-03 | 43 | 72 | 3 | M47773 | |
| Pathway | WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS | 1.37e-03 | 11 | 72 | 2 | M48094 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.40e-03 | 95 | 72 | 4 | M6729 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.55e-03 | 45 | 72 | 3 | M47670 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 1.55e-03 | 45 | 72 | 3 | M39474 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.57e-03 | 98 | 72 | 4 | M776 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.63e-03 | 99 | 72 | 4 | M27474 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.63e-03 | 99 | 72 | 4 | MM14986 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 1.75e-03 | 170 | 72 | 5 | M941 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.76e-03 | 47 | 72 | 3 | M19708 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.82e-03 | 102 | 72 | 4 | M27648 | |
| Pathway | WP_DISORDERS_OF_GALACTOSE_METABOLISM | 1.93e-03 | 13 | 72 | 2 | M45545 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 1.93e-03 | 13 | 72 | 2 | MM14516 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 2.23e-03 | 51 | 72 | 3 | MM15928 | |
| Pathway | WP_DISORDERS_OF_FRUCTOSE_METABOLISM | 2.25e-03 | 14 | 72 | 2 | M45540 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 2.36e-03 | 52 | 72 | 3 | M14171 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | ARHGEF28 TUBA3D UNC5B SLIT1 PSMB9 TUBA3E ITGA2 TUBA3C TUBAL3 | 2.53e-03 | 575 | 72 | 9 | M29853 |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.59e-03 | 15 | 72 | 2 | M552 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.65e-03 | 113 | 72 | 4 | M27471 | |
| Pathway | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | 2.95e-03 | 16 | 72 | 2 | MM15710 | |
| Pathway | REACTOME_KINESINS | 3.07e-03 | 57 | 72 | 3 | MM15714 | |
| Pathway | WP_CORI_CYCLE | 3.33e-03 | 17 | 72 | 2 | M39604 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.33e-03 | 17 | 72 | 2 | MM14731 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.33e-03 | 17 | 72 | 2 | M47905 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.49e-03 | 288 | 72 | 6 | M16864 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 3.54e-03 | 200 | 72 | 5 | M864 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | 3.78e-03 | 203 | 72 | 5 | M27654 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.86e-03 | 204 | 72 | 5 | M4217 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.92e-03 | 126 | 72 | 4 | M705 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.94e-03 | 205 | 72 | 5 | M752 | |
| Pathway | BIOCARTA_LONGEVITY_PATHWAY | 4.16e-03 | 19 | 72 | 2 | MM1513 | |
| Pathway | REACTOME_LDL_CLEARANCE | 4.16e-03 | 19 | 72 | 2 | M27846 | |
| Pubmed | 6.79e-09 | 9 | 96 | 4 | 19554504 | ||
| Pubmed | 1.13e-06 | 8 | 96 | 3 | 15802388 | ||
| Pubmed | 1.69e-06 | 9 | 96 | 3 | 21167302 | ||
| Pubmed | 4.40e-06 | 12 | 96 | 3 | 27477018 | ||
| Pubmed | The human growth hormone gene family: structure and evolution of the chromosomal locus. | 7.54e-06 | 2 | 96 | 2 | 6306568 | |
| Pubmed | Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells. | 7.54e-06 | 2 | 96 | 2 | 28618103 | |
| Pubmed | MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function. | 7.54e-06 | 2 | 96 | 2 | 35121660 | |
| Pubmed | Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking. | 7.54e-06 | 2 | 96 | 2 | 38240799 | |
| Pubmed | Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. | 7.54e-06 | 2 | 96 | 2 | 11688999 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 30892081 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 16332677 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11483364 | ||
| Pubmed | Cell proliferation and vascularization in mouse models of pituitary hormone deficiency. | 9.05e-06 | 15 | 96 | 3 | 16556738 | |
| Pubmed | 1.91e-05 | 19 | 96 | 3 | 15691386 | ||
| Pubmed | 1.91e-05 | 19 | 96 | 3 | 15698476 | ||
| Pubmed | Specificity change of antibody to (4-hydroxy-3-nitrophenyl)acetyl haptens by somatic hypermutation. | 2.26e-05 | 3 | 96 | 2 | 3129412 | |
| Pubmed | Specific V gene usage in anti-phosphorylcholine IgE antibodies. | 2.26e-05 | 3 | 96 | 2 | 8247027 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11994274 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 26855992 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10562316 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 21738833 | ||
| Pubmed | High frequency expression of S107 VH genes by peritoneal B cells of B10.H-2aH-4bP/WTS mice. | 2.26e-05 | 3 | 96 | 2 | 2117034 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11359880 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 6265582 | ||
| Pubmed | Somatic variants of murine immunoglobulin lambda light chains. | 2.26e-05 | 3 | 96 | 2 | 6283385 | |
| Pubmed | Genetic polymorphism of lambda 1 and lambda 3 immunoglobulin light chains in the Mus subgenus. | 2.26e-05 | 3 | 96 | 2 | 6189723 | |
| Pubmed | Sequence of a mouse germ-line gene for a variable region of an immunoglobulin light chain. | 2.26e-05 | 3 | 96 | 2 | 418414 | |
| Pubmed | Dual expression of lambda genes in the MOPC-315 plasmacytoma. | 2.26e-05 | 3 | 96 | 2 | 6259534 | |
| Pubmed | Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression. | 2.26e-05 | 3 | 96 | 2 | 14595650 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 1918968 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 403522 | ||
| Pubmed | Nucleotide sequence of a chromosomal rearranged lambda 2 immunoglobulin gene of mouse. | 2.26e-05 | 3 | 96 | 2 | 6287422 | |
| Pubmed | Amino acid sequence of the light chain of a mouse myeloma protein (MOPC-315). | 2.26e-05 | 3 | 96 | 2 | 4760498 | |
| Pubmed | Sequences of 12 monoclonal anti-dinitrophenyl spin-label antibodies for NMR studies. | 2.26e-05 | 3 | 96 | 2 | 3375235 | |
| Pubmed | Lambda light chain constant and variable gene complements in wild-derived inbred mouse strains. | 2.26e-05 | 3 | 96 | 2 | 3924628 | |
| Pubmed | Functional, molecular and structural characterisation of five anti-Brucella LPS mAb. | 2.26e-05 | 3 | 96 | 2 | 15128040 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 4516208 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 98276 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8318454 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10427979 | ||
| Pubmed | Amino acid sequences of two mouse immunoglobulin lambda chains. | 2.26e-05 | 3 | 96 | 2 | 5276767 | |
| Pubmed | Structural evidence for the functional importance of the heme domain mobility in flavocytochrome b2. | 2.26e-05 | 3 | 96 | 2 | 20546754 | |
| Pubmed | Sequences of mouse immunoglobulin light chain genes before and after somatic changes. | 2.26e-05 | 3 | 96 | 2 | 103630 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8647454 | ||
| Pubmed | Chromosomal localization of the human placental lactogen-growth hormone gene cluster to 17q22-24. | 2.26e-05 | 3 | 96 | 2 | 7072716 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11920561 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 7643860 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 6202790 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 14754898 | ||
| Pubmed | Mouse immunoglobulin gene rearrangements. The sequence of a nonexpressed lambda 3-chain gene. | 2.26e-05 | 3 | 96 | 2 | 2987352 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 1378065 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8232332 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8805642 | ||
| Pubmed | A linkage map of the mouse immunoglobulin lambda light chain locus. | 2.26e-05 | 3 | 96 | 2 | 2494106 | |
| Pubmed | Comparative sequence and immunochemical analyses of murine monoclonal anti-morphine antibodies. | 2.26e-05 | 3 | 96 | 2 | 2555519 | |
| Pubmed | Mutational analysis of avidity and fine specificity of anti-levan antibodies. | 2.26e-05 | 3 | 96 | 2 | 10586066 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 2453579 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 9032408 | ||
| Pubmed | Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP. | 2.26e-05 | 3 | 96 | 2 | 2430792 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 28708422 | ||
| Pubmed | Store-independent activation of Orai1 by SPCA2 in mammary tumors. | 2.26e-05 | 3 | 96 | 2 | 20887894 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 418802 | ||
| Pubmed | Physical linkage of the constant region genes for immunoglobulins lambda I and lambda III. | 2.26e-05 | 3 | 96 | 2 | 6267606 | |
| Pubmed | A new V gene expressed in lambda-2 light chains of the mouse. | 2.26e-05 | 3 | 96 | 2 | 3034625 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8190131 | ||
| Pubmed | Molecular and biochemical analyses of combining sites of monoclonal anti-morphine antibodies. | 2.26e-05 | 3 | 96 | 2 | 8417377 | |
| Pubmed | Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas. | 2.26e-05 | 3 | 96 | 2 | 3139765 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 3.02e-05 | 22 | 96 | 3 | 23826228 | |
| Pubmed | 3.02e-05 | 22 | 96 | 3 | 28117675 | ||
| Pubmed | 3.95e-05 | 24 | 96 | 3 | 8833235 | ||
| Pubmed | SMARCA5 HK1 PCDHGA6 PCDHGA1 ASH1L SMARCA1 ABCC5 MACF1 APOB PLEC MLPH SLC4A11 CFAP46 RPS6KC1 | 4.15e-05 | 1442 | 96 | 14 | 35575683 | |
| Pubmed | SPCA2 regulates Orai1 trafficking and store independent Ca2+ entry in a model of lactation. | 4.51e-05 | 4 | 96 | 2 | 23840669 | |
| Pubmed | Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. | 4.51e-05 | 4 | 96 | 2 | 25904018 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 21365679 | ||
| Pubmed | B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. | 4.51e-05 | 4 | 96 | 2 | 7722301 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 29656212 | ||
| Pubmed | A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum. | 4.51e-05 | 4 | 96 | 2 | 11536079 | |
| Pubmed | Linkage of the Igl-1 structural and regulatory genes to Akv-2 on chromosome 16. | 4.51e-05 | 4 | 96 | 2 | 6429038 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 7169009 | ||
| Pubmed | High 18F-FDG uptake in PMAH correlated with normal expression of Glut1, HK1, HK2, and HK3. | 4.51e-05 | 4 | 96 | 2 | 25766729 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 1431128 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 3109891 | ||
| Pubmed | δβγ-ENaC is inhibited by CFTR but stimulated by cAMP in Xenopus laevis oocytes. | 4.51e-05 | 4 | 96 | 2 | 27941075 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 8943276 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 4.98e-05 | 235 | 96 | 6 | 28378594 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 5.47e-05 | 146 | 96 | 5 | 20686565 | |
| Pubmed | 6.62e-05 | 152 | 96 | 5 | 34299191 | ||
| Pubmed | ARFGEF3 PITPNM2 CAD ATP2C1 ACACA DSG1 DLGAP4 MACF1 PLEC BIRC6 VPS37B RPS6KC1 | 7.14e-05 | 1139 | 96 | 12 | 36417873 | |
| Pubmed | Central growth hormone action regulates metabolism during pregnancy. | 7.50e-05 | 5 | 96 | 2 | 31479305 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 10767558 | ||
| Pubmed | Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. | 7.50e-05 | 5 | 96 | 2 | 8496314 | |
| Pubmed | Exploring endocrine GH pattern in mice using rank plot analysis and random blood samples. | 7.50e-05 | 5 | 96 | 2 | 21045135 | |
| Pubmed | Analysis of gender difference of cardiac risk biomarkers using hGH-transgenic mice. | 7.50e-05 | 5 | 96 | 2 | 16508206 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 18006625 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 15616010 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 19019400 | ||
| Pubmed | The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH? | 7.50e-05 | 5 | 96 | 2 | 32556100 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 1525063 | ||
| Pubmed | Obesity and elevated plasma leptin concentration in oMT1A-o growth hormone transgenic mice. | 7.50e-05 | 5 | 96 | 2 | 11346667 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 12010633 | ||
| Interaction | ABCC11 interactions | 1.82e-06 | 6 | 92 | 3 | int:ABCC11 | |
| GeneFamily | ATP binding cassette subfamily C | 6.99e-10 | 13 | 66 | 5 | 807 | |
| GeneFamily | Tubulins | 2.28e-06 | 26 | 66 | 4 | 778 | |
| GeneFamily | Solute carriers | SLC17A2 SLC46A2 SLC25A41 SLC18A1 SLC2A6 SLC40A1 SLC2A2 SLC4A11 | 9.18e-05 | 395 | 66 | 8 | 752 |
| GeneFamily | Growth hormone family | 1.95e-04 | 6 | 66 | 2 | 1175 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.62e-04 | 8 | 66 | 2 | 939 | |
| GeneFamily | ATPases Ca2+ transporting | 4.65e-04 | 9 | 66 | 2 | 1209 | |
| GeneFamily | Apolipoproteins | 2.64e-03 | 21 | 66 | 2 | 405 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-09 | 175 | 96 | 8 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.86e-07 | 190 | 96 | 7 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.38e-07 | 197 | 96 | 7 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 168 | 96 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 168 | 96 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 169 | 96 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-06 | 169 | 96 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.68e-06 | 181 | 96 | 6 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.10e-06 | 104 | 96 | 5 | 5d9cd14e53a2f1060e528abf6c0694be9d72c356 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.33e-06 | 188 | 96 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-06 | 188 | 96 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.54e-06 | 190 | 96 | 6 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 3.54e-06 | 190 | 96 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.65e-06 | 191 | 96 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.76e-06 | 192 | 96 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.25e-06 | 61 | 96 | 4 | 46cdf693c7f2df4fc43df7837b152871af67bef0 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.25e-06 | 61 | 96 | 4 | c73fa489427a6e11badbdfc0324008137806ac7d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6.Tcf4_(Supramammillary_Nucleus_(SuM))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 9.25e-06 | 61 | 96 | 4 | c2c633f49f6ad8581c33794c909f40aa59f0b5c5 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.03e-05 | 153 | 96 | 5 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Neuron.Gad1Gad2-Chat-Slc17a8.Chat_(cholinergic_interneuron)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.22e-05 | 76 | 96 | 4 | 3073a8ace46ad18bddd22ec8f3a1b59ee2fd989d | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat-Inhibitory_Neuron.Gad1Gad2-Chat-Slc17a8.Chat_(cholinergic_interneuron)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.22e-05 | 76 | 96 | 4 | 3f5865b9cb6648b88eb873018e513c5efb457ae5 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN2(Gad1Gad2)-Chat|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.22e-05 | 76 | 96 | 4 | 041a8984b3ae4bb03ae6db8234c1333ac73098fa | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 156 | 96 | 5 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue-4|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.30e-05 | 157 | 96 | 5 | 2553ebf3e48de5bd184e77bd61114faa5a1d95ed | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 160 | 96 | 5 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 160 | 96 | 5 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.72e-05 | 80 | 96 | 4 | 54f520cca126810510479fbeade2e3f66fb5dd1b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.72e-05 | 80 | 96 | 4 | ce38ea123853a1e1082a033fb779b63ea440661d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-05 | 165 | 96 | 5 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 170 | 96 | 5 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | TCGA-Liver|World / Sample_Type by Project: Shred V9 | 3.76e-05 | 174 | 96 | 5 | 452932f08cf53e5949672a025d78cecb874aa4b0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 179 | 96 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.53e-05 | 181 | 96 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.77e-05 | 183 | 96 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 183 | 96 | 5 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 4.90e-05 | 184 | 96 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 184 | 96 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.16e-05 | 186 | 96 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 5.43e-05 | 188 | 96 | 5 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 189 | 96 | 5 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.56e-05 | 189 | 96 | 5 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.99e-05 | 192 | 96 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-05 | 192 | 96 | 5 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.77e-05 | 197 | 96 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.77e-05 | 197 | 96 | 5 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.93e-05 | 198 | 96 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-05 | 198 | 96 | 5 | e8bfae3888b2406b5629b576cb02913b3297337e | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.10e-05 | 199 | 96 | 5 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 200 | 96 | 5 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 200 | 96 | 5 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 7.27e-05 | 200 | 96 | 5 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.27e-05 | 200 | 96 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Biopsy_Control_(H.)-Epithelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 0afd93c4fdcc118bcfa77f3b59f6ff7d9293a7a4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_ALM_Oprk1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-04 | 47 | 96 | 3 | b83e9a0f8db3f1581c5621f9d835ae2423ba0978 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.85e-04 | 131 | 96 | 4 | 308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.08e-04 | 135 | 96 | 4 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| Drug | 1 sulfonylurea | 2.16e-06 | 143 | 94 | 7 | CID011819083 | |
| Drug | glibenclamide | 4.06e-06 | 382 | 94 | 10 | CID000003488 | |
| Drug | adefovir | 6.78e-06 | 64 | 94 | 5 | CID000060172 | |
| Drug | orthovanadate | 1.26e-05 | 435 | 94 | 10 | CID000061672 | |
| Drug | acadesine | 1.39e-05 | 126 | 94 | 6 | CID000017513 | |
| Drug | 1,12-dichlorododecane | 1.69e-05 | 2 | 94 | 2 | CID000077523 | |
| Drug | T0901317 | 2.15e-05 | 81 | 94 | 5 | CID000447912 | |
| Drug | nickel(II) acetate | 2.40e-05 | 14 | 94 | 3 | CID000009756 | |
| Drug | 5-(tetradecyloxy)-2-furoic acid | 2.99e-05 | 15 | 94 | 3 | CID000115175 | |
| Drug | verapamil | ADCY4 ATP2C1 CFTR ATP2C2 SCNN1D ABCC5 ABCC12 APOB BIRC6 ABCC6 | 3.49e-05 | 490 | 94 | 10 | CID000002520 |
| Drug | AC1Q6RZL | 4.24e-05 | 47 | 94 | 4 | CID000001144 | |
| Drug | Mirex | 4.61e-05 | 48 | 94 | 4 | ctd:D008917 | |
| Drug | DMNPE | 5.05e-05 | 3 | 94 | 2 | CID000196727 | |
| Drug | 2-(aminomethyl)pyrrolidine | 5.55e-05 | 161 | 94 | 6 | CID000072032 | |
| Drug | UTP-NA | 6.05e-05 | 420 | 94 | 9 | CID000001181 | |
| Drug | palmitoylcarnitine | 6.54e-05 | 102 | 94 | 5 | CID000000461 | |
| Drug | NSC316735 | 6.54e-05 | 102 | 94 | 5 | CID000000422 | |
| Drug | AC1L494B | 6.83e-05 | 53 | 94 | 4 | CID000181487 | |
| Drug | NSC 226836 | 7.38e-05 | 20 | 94 | 3 | CID000012600 | |
| Drug | alloxan | 7.51e-05 | 105 | 94 | 5 | CID000005781 | |
| Drug | pralatrexate | 8.59e-05 | 21 | 94 | 3 | CID000148121 | |
| Drug | AC1Q5X3R | 9.91e-05 | 22 | 94 | 3 | CID000108075 | |
| Drug | beta-hydroxybutyrate | 9.97e-05 | 179 | 94 | 6 | CID000000441 | |
| Drug | lofenal | 1.01e-04 | 4 | 94 | 2 | CID000159256 | |
| Drug | Fluorodeoxyuridylate | 1.01e-04 | 4 | 94 | 2 | ctd:D005468 | |
| Drug | N-bromoacetylglucosamine | 1.01e-04 | 4 | 94 | 2 | CID000152920 | |
| Drug | UCl4 | 1.01e-04 | 4 | 94 | 2 | CID000066210 | |
| Drug | AC1L5VHN | 1.01e-04 | 4 | 94 | 2 | CID000235938 | |
| Drug | 2,3-anhydro-D-allose | 1.01e-04 | 4 | 94 | 2 | CID000191595 | |
| Drug | 2 Ni | 1.01e-04 | 4 | 94 | 2 | CID005326979 | |
| Drug | AC1L8S00 | 1.01e-04 | 4 | 94 | 2 | CID000431721 | |
| Drug | Dikar | 1.01e-04 | 4 | 94 | 2 | CID006433517 | |
| Drug | 1,5-anhydroglucitol 6-phosphate | 1.01e-04 | 4 | 94 | 2 | CID003081444 | |
| Drug | 1-deoxy-D-manno-heptulose | 1.01e-04 | 4 | 94 | 2 | CID000193198 | |
| Drug | grepafloxacin glucuronide | 1.01e-04 | 4 | 94 | 2 | CID000443296 | |
| Drug | Laevuflex | 1.36e-04 | 272 | 94 | 7 | CID000003426 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 1.47e-04 | 25 | 94 | 3 | CID000062529 | |
| Drug | 3-chloromethylthiochromone-1,1-dioxide | 1.67e-04 | 5 | 94 | 2 | CID000100620 | |
| Drug | Bay P 8857 | 1.67e-04 | 5 | 94 | 2 | CID003086449 | |
| Drug | cose | 1.67e-04 | 5 | 94 | 2 | CID000137100 | |
| Drug | trichlorosilane | 1.67e-04 | 5 | 94 | 2 | CID000140487 | |
| Drug | D-mannoheptulose hexaacetate | 1.67e-04 | 5 | 94 | 2 | CID000538767 | |
| Drug | 2-fluoro-2-deoxy-6-phosphogluconate | 1.67e-04 | 5 | 94 | 2 | CID000127270 | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; HL60; HG-U133A | 1.73e-04 | 198 | 94 | 6 | 1601_DN | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; PC3; HT_HG-U133A | 1.78e-04 | 199 | 94 | 6 | 5888_DN | |
| Disease | microlissencephaly (implicated_via_orthology) | 1.62e-06 | 8 | 92 | 3 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.62e-06 | 8 | 92 | 3 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.62e-06 | 8 | 92 | 3 | DOID:0080918 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.20e-05 | 702 | 92 | 11 | C0009402 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.78e-05 | 60 | 92 | 4 | EFO_0022233 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 7.05e-05 | 222 | 92 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | lissencephaly (implicated_via_orthology) | 8.13e-05 | 27 | 92 | 3 | DOID:0050453 (implicated_via_orthology) | |
| Disease | isolated growth hormone deficiency type II (implicated_via_orthology) | 9.56e-05 | 5 | 92 | 2 | DOID:0060872 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.06e-04 | 239 | 92 | 6 | EFO_0010934 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.06e-04 | 239 | 92 | 6 | EFO_0008317, EFO_0020945 | |
| Disease | arteriosclerosis (is_implicated_in) | 1.24e-04 | 31 | 92 | 3 | DOID:2349 (is_implicated_in) | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 1.43e-04 | 6 | 92 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | GH1 PITPNM2 ADCY4 SLC18A1 TMEM160 DLGAP4 SLIT1 ANKRD11 MACF1 APOB PLEC MTARC1 | 1.66e-04 | 1106 | 92 | 12 | EFO_0021796 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.82e-04 | 264 | 92 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 2.00e-04 | 7 | 92 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.31e-04 | 276 | 92 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 3.09e-04 | 103 | 92 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | glycogen storage disease (is_implicated_in) | 3.41e-04 | 9 | 92 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 3.41e-04 | 9 | 92 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.17e-04 | 50 | 92 | 3 | EFO_0022247 | |
| Disease | diabetic retinopathy (is_implicated_in) | 5.17e-04 | 50 | 92 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 5.19e-04 | 11 | 92 | 2 | OBA_2045170 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.69e-04 | 121 | 92 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | protein FAM3D measurement | 6.22e-04 | 12 | 92 | 2 | EFO_0021869 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 6.83e-04 | 127 | 92 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.08e-04 | 225 | 92 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | CD209 antigen measurement | 8.54e-04 | 14 | 92 | 2 | EFO_0008077 | |
| Disease | congenital hypothyroidism (biomarker_via_orthology) | 8.54e-04 | 14 | 92 | 2 | DOID:0050328 (biomarker_via_orthology) | |
| Disease | anemia (is_implicated_in) | 8.54e-04 | 14 | 92 | 2 | DOID:2355 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 9.99e-04 | 243 | 92 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | central nervous system disease (implicated_via_orthology) | 1.12e-03 | 16 | 92 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.22e-03 | 67 | 92 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.22e-03 | 67 | 92 | 3 | EFO_0022245 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.27e-03 | 150 | 92 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement | 1.27e-03 | 17 | 92 | 2 | EFO_0008011 | |
| Disease | Hypercholesterolemia, Familial | 1.42e-03 | 18 | 92 | 2 | C0020445 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 1.44e-03 | 71 | 92 | 3 | EFO_0022259 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.62e-03 | 74 | 92 | 3 | EFO_0022280 | |
| Disease | e-selectin measurement | 2.13e-03 | 22 | 92 | 2 | EFO_0004575 | |
| Disease | osteoporosis (biomarker_via_orthology) | 2.13e-03 | 22 | 92 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Sarcosine measurement | 2.33e-03 | 23 | 92 | 2 | EFO_0021668 | |
| Disease | Coronary heart disease | 2.54e-03 | 24 | 92 | 2 | C0010068 | |
| Disease | Dyslipidemias | 2.54e-03 | 24 | 92 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.54e-03 | 24 | 92 | 2 | C0598784 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.62e-03 | 303 | 92 | 5 | EFO_0004612, EFO_0020945 | |
| Disease | bilirubin measurement | 2.63e-03 | 442 | 92 | 6 | EFO_0004570 | |
| Disease | mental development measurement | 2.75e-03 | 25 | 92 | 2 | EFO_0008230 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARSLSGLQLGSDVMF | 241 | Q495M9 | |
| TAMLGLGSDSEGFSR | 6 | Q9NR48 | |
| TRKAGLLFGMGLSGI | 91 | Q6UB99 | |
| GVADTLLAMGFFRGL | 921 | P13569 | |
| GLDLSGHAGMLTLTS | 1191 | Q9NR09 | |
| LLGAFTGASMRGLTL | 1306 | Q7Z407 | |
| FLLSGLGGLRMDSNF | 6 | Q99965 | |
| MLRGRSLSVTSLGGL | 1 | P54840 | |
| NSGRFSMGSVVAGLL | 301 | Q9H845 | |
| GGIAGSSALVMLAAR | 1021 | Q8IYW2 | |
| NLRGSGMIAGESSLA | 1796 | Q13085 | |
| LSLYNMSSAGGDRLG | 186 | A6QL63 | |
| LGMRDAAVAGLASSL | 136 | Q8NFM4 | |
| HLAIGSAATLGSGGM | 381 | Q15027 | |
| IRGLHGSRTMAGASS | 191 | Q96J87 | |
| GAFRSSGPASGLMTL | 216 | Q9Y2H0 | |
| RMGSAGLRVLALASG | 516 | P98194 | |
| RMGSLGLRVLALASG | 546 | O75185 | |
| TLLAAGRLSDMLNGG | 356 | Q8N1W1 | |
| MLSGIGRKVSSLFGI | 251 | Q8WUM0 | |
| KSRLLQASGGGLASM | 721 | Q9Y5G7 | |
| MGAAGSSALARFVLL | 1 | Q5VT66 | |
| SYSSMLGAVAGLALG | 326 | Q8NBP5 | |
| FESRGSDGGSMLKAL | 456 | Q96S38 | |
| LHLAAGRGLMGISST | 441 | O00221 | |
| MAALGGDGLRLLSVS | 1 | Q9Y256 | |
| LSLRRSSLGVGIGSM | 1371 | Q86VH2 | |
| LEFGLGGSSMSTHLR | 276 | Q63HM2 | |
| EKAGRRSLFLIGMSG | 361 | P11168 | |
| RTGSGKSSLGMALFR | 1176 | Q96J66 | |
| FMSRTSINGLLGRGS | 111 | Q9H1A3 | |
| SINGLLGRGSMFVFS | 116 | Q9H1A3 | |
| LAMSRDGSSGGVIYL | 181 | P28065 | |
| SSSTMLDGTGALGRF | 701 | Q9BZ72 | |
| RFLLSESGSGKGAAM | 441 | P19367 | |
| GAFGDDGSLAMLSTR | 716 | P52790 | |
| SVFTLGAAAGGLSAM | 86 | Q9UGQ3 | |
| GLILTRNMGTGGFLT | 116 | P17301 | |
| TLGASMDAGTILRGS | 306 | Q96ES6 | |
| IGLSSLGGTASIGHM | 1001 | Q02413 | |
| ARFSGSLLGGKAALT | 81 | P04211 | |
| GRLMLLSRDDSGSGS | 6396 | Q9UPN3 | |
| LEMTAGFGLGGLRLT | 201 | Q96IR7 | |
| RMFEAAAVGSLLAGG | 286 | O15440 | |
| VGRTGSGKSSLGMAL | 1226 | O15440 | |
| ALGGGKLEATFTFMR | 56 | Q9NPH6 | |
| GLSGASMKLTTNGRF | 1676 | P04114 | |
| RGSSGFLRASGDMLK | 276 | Q86XA9 | |
| LELMATGFLRGGSGF | 271 | Q9P2D3 | |
| TGRMAGSSKGLAFIL | 881 | Q5TH69 | |
| VFLLSTRAGGVGMNL | 416 | Q86WJ1 | |
| LDAMSGRLGRAGTFL | 96 | Q9H222 | |
| AAGMSGAGRALAALL | 26 | Q68CP4 | |
| AFMLALRSGFSGALL | 1521 | Q8IWT3 | |
| GLGGMLFSRFGRSST | 756 | Q8NEL9 | |
| GTGLGDSSMAFLSRT | 91 | P51172 | |
| ARFSGSLLGGKAALT | 81 | A0A075B6I9 | |
| GSHRMALGTAAALGS | 281 | Q9BV36 | |
| TAAMALLAGGLSRGL | 46 | Q86X29 | |
| KSRLLQASGGGLASM | 721 | Q9Y5H4 | |
| IGFLAARAFLRSGGM | 26 | P84550 | |
| SLSLRAVSGAMGLGF | 636 | Q8NBS3 | |
| SKFIFMLSTRAGGLG | 566 | P28370 | |
| MLSTRAGGLGINLAS | 571 | P28370 | |
| LGSAAGIAIMTSLFG | 231 | Q5TGY1 | |
| GLFASMAAVLLGGAR | 1001 | O95255 | |
| MRALRAGLTLASGAG | 1 | Q14249 | |
| LLMATLQAGFGRTGL | 16 | Q68DV7 | |
| LLSGAMAGAVSRTGT | 96 | Q8N5S1 | |
| GLSGSILSILMGASA | 336 | Q9NP59 | |
| GTGSGFTSLLMERLT | 151 | A6NHL2 | |
| TGSGKSSLGMALFRL | 1156 | Q96J65 | |
| SLMLSATGTGLGAAA | 166 | Q9BWW9 | |
| FVLLLSGMGATGTLR | 11 | Q9H6E4 | |
| LTDTGRFGVGMAILS | 81 | Q6RW13 | |
| MAAGSRTSLLLAFGL | 1 | P01242 | |
| GSGFASLLMERLSVD | 146 | P0DPH8 | |
| NGGLLFRMTLLTSGG | 266 | Q5T4D3 | |
| LLTMALAGGSGTASA | 21 | Q9BXS4 | |
| LEAGSGSGGMSLFLS | 251 | Q9BVS5 | |
| LAGASITGSLSGSAM | 541 | Q9NV58 | |
| MDSLGAVSTRLGFDL | 1 | Q9UIV8 | |
| GSGFASLLMERLSVD | 146 | P0DPH7 | |
| ASFLMGISRGFGLIA | 406 | O00624 | |
| ESMGLLASERSGGSL | 171 | Q96FA7 | |
| MATGSRTSLLLAFGL | 1 | P01241 | |
| VFLGGRSMGSRAAAS | 96 | Q5JUR7 | |
| DMLSGNAGGFRSRSS | 4371 | Q15149 | |
| MGARSGARGALLLAL | 1 | Q8IZJ1 | |
| SMRGAGGRRLSSFVT | 1396 | P27708 | |
| AAAMARLGGAVLSFS | 1981 | P27708 | |
| GGSIRSMAAAALSGL | 11 | Q96HG1 | |
| VMALGSLGSSEGRRS | 156 | Q9BY10 | |
| FSLVRMAGGTALLAA | 446 | Q8TEQ8 | |
| GSGFASLLMERLSVD | 146 | Q6PEY2 | |
| RNGLLASGIGVISFM | 76 | Q9NX00 | |
| TKFVFMLSTRAGGLG | 551 | O60264 | |
| MLSTRAGGLGINLAT | 556 | O60264 | |
| LESIRSGMFRGLDGL | 601 | O75093 | |
| LLSSLLGGSQAMDGR | 6 | Q96LC7 | |
| MAGAGSEARFAGLSL | 1 | Q9H9H4 | |
| GIGSSFSSVAGLGML | 201 | P54219 |